Navigation Links
New Evidence Found for CRP as an Independent Marker for Heart Disease, Stroke
Date:11/17/2008

A new study published in the New England Journal of Medicine lends further importance to the screening of C-reactive protein (CRP) in the detection of heart disease and stroke risk. Life Line Screening provides CRP screening along with glucose and cholesterol screenings.

Cleveland, OH (PRWeb) November 17, 2008 -- New clinical evidence indicates that a measurement called high-sensitivity C-reactive protein (CRP) is an independent marker that can pinpoint those at risk for stroke or heart attack even when cholesterol measurements are normal. Life Line Screening, the nation's leading provider of community-based preventive health screenings, includes testing for this risk indicator among its services.

Healthcare professionals traditionally view high levels of low-density lipoprotein (LDL) or "bad cholesterol" as the primary blood measurement for stroke and heart disease risk.

"Attention to CRP should not be avoided, as the new study in the NEJM indicates," states Andrew Manganaro, MD, FACS, FACC, Chief Medical Officer of Life Line Screening. "The results of this study shed light on the fact that half of all cardiovascular events occur in people without high cholesterol. The need to screen for other potential risk indicators is clear, and the medical community is beginning to explore this fact. We are proud to be able to offer the CRP screening along with our other testing services."

CRP is a marker of inflammation in the body. Previous studies suggested that its significance for cardiovascular disease was limited to cases in which it was coupled with a high LDL measurement. The new study, published in the New England Journal of Medicine, now reveals that CRP is an effective independent predictor for increased risk of heart disease, even among individuals whose LDL cholesterol counts were found to be at normal levels. These new findings are prompting the medical community to take a new look at how they identify at-risk individuals.

About Life Line Screening
Life Line Screening, the nation's leading provider of preventive health screenings, offers a simple finger-stick blood test that checks for elevated CRP levels, in most states. Results are ready minutes after the screening and can provide a better understanding of a person's risk for heart disease and stroke. Finger-stick blood tests for diabetes and cholesterol levels are also available.

All three screenings--CRP, glucose and cholesterol--are available for $70.

For more information regarding the screenings or to schedule an appointment, call 1-800-697-9721 or visit www.lifelinescreening.com. Pre-registration is required.

###

Read the full story at http://www.prweb.com/releases/CRP-study/CRP-screening/prweb1618124.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Jefferson researchers uncover new evidence of prolactins possible role in breast cancer
2. No strong evidence linking amateur boxing with long-term brain injury
3. AHRQ Announces Next Phase of Its Evidence-Based Practice Center Program
4. Vanderbilt Medical Center chosen as Evidence-based Practice Center
5. Little Evidence Silicone Breast Implants Harm Health
6. Consumers Should Demand Evidence, Not Guesswork, On Meat-Cancer Links
7. U of M study: Medicare lacks tools, incentives to enforce evidence-based coverage policies
8. New Study Provides Scientific Evidence That DermaLastyl Face Cream Reduces Wrinkles
9. Scientific evidence of the significant anti-cancer effect of milk thistle
10. Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace
11. UC Davis researchers find evidence of mature heart cell potential in embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Evidence Found for CRP as an Independent Marker for Heart Disease, Stroke 
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to ... Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed a ... or restricted lighting. As such, it eliminates the need to turn on a light ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids ... Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, ... run is geared towards children of all ages; it is a non-competitive, non-timed event, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: